shadow

By the end of this year, India is likely to have about half a dozen vaccines. US biotechnology company Novovax, Gennova Biopharmaceuticals, Zydus Cadila and other pharma companies are expected to roll out their vaccines in India by the end of 2021. Meanwhile, Prime Minister Narendra Modi has said that vaccine wastage numbers are still on a higher side which needs to be brought down.

The Maharashtra government has announced that it will lift lockdown restrictions from Monday through its five-level unlock plan. The lockdown in Maharashtra will be relaxed on the basis of Covid positivity rate and availability of oxygen beds in the state. Meanwhile, the Punjab government has withdrawn its decision to provide one-time limited Covid-19 vaccine doses for people in the 18-44 years age group to private hospitals because it had “not been taken in the right spirit”.

Punjab govt withdraws decision to sell Covid vaccines to private hospitals

The Punjab government on Friday withdrew its decision to provide one-time limited Covid-19 vaccine doses for people in the 18-44 years age group to private hospitals because it had “not been taken in the right spirit”. The government has directed private hospitals to return all the vaccine doses that are available with them. Additionally, doses that have been utilised also have to be returned once the private hospitals get direct supply from vaccine manufacturers.

Maharashtra to unlock from Monday: All you need to know

In a late-night development on Friday, the Maharashtra government announced that it will lift lockdown restrictions from Monday through its five-level unlock plan. The lockdown in Maharashtra will be relaxed on the basis of Covid positivity rate and availability of oxygen beds in the state. The order will be implemented from Monday. Here are all the details you need to know about the five-level unlock plan in Maharashtra

DCGI grants Serum Institute permission to manufacture Sputnik V Covid vaccine in India

The Drugs Controller General of India (DCGI) on Friday granted the Serum Institute of India permission to manufacture Russian Covid-19 vaccine Sputnik V in India.

The Serum Institute of India (SII) has been granted approval to manufacture the vaccine for examination, test and analysis with certain conditions at its licensed facility in Hadapsar, Pune. SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia to develop Sputnik V in India.

Author

India today

Leave a Reply

Your email address will not be published.